{"id":517364,"date":"2021-07-26T08:03:33","date_gmt":"2021-07-26T12:03:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/"},"modified":"2021-07-26T08:03:33","modified_gmt":"2021-07-26T12:03:33","slug":"4d-pharma-announces-passing-of-chief-financial-officer-john-beck","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/","title":{"rendered":"4D pharma Announces Passing of Chief Financial Officer John Beck"},"content":{"rendered":"

<\/p>\n

4D pharma Announces Passing of Chief Financial Officer John Beck<\/b><\/p>\n

LEEDS, England–(BUSINESS WIRE<\/a>)–4D pharma plc (AIM: DDDD, NASDAQ, LBPS)<\/b>, a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, announces with great sadness that John Beck, Chief Financial Officer of 4D pharma, has passed away.\n<\/p>\n

\n\u201cWe are deeply saddened by John\u2019s passing. The entire 4D pharma community mourns this loss and, on behalf of our Board of Directors and employees, we extend our sincerest condolences to his family,\u201d said Duncan Peyton, Chief Executive Officer of 4D pharma. \u201cJohn\u2019s 30 years of experience in the financial and biopharmaceutical industries were invaluable to us in his role as Chief Financial Officer, and his vision for the future of 4D pharma was already well on its way to being realized. We grieve this loss and will carry his legacy forward in this next chapter of 4D pharma continued growth and progress.\u201d\n<\/p>\n

\n4D pharma will continue to be actively led by its current management team and Board of Directors and succession planning is underway.\n<\/p>\n

About 4D pharma<\/strong><\/p>\n

\n4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx\u00ae, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.\n<\/p>\n

\n4D pharma’s Live Biotherapeutic products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut. The Company has five clinical programs, namely a Phase I\/II study of MRx0518 in combination with KEYTRUDA (pembrolizumab) in solid tumors, a Phase I study of MRx0518 in a neoadjuvant setting for patients with solid tumors, a Phase I study of MRx0518 in patients with pancreatic cancer, a Phase I\/II study of MRx-4DP0004 in asthma, and Blautix\u00ae in Irritable Bowel Syndrome (IBS) which has completed a successful Phase II trial. Preclinical-stage programs include candidates for CNS disease such as Parkinson’s disease and other neurodegenerative conditions. The Company has a research collaboration with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ, USA, to discover and develop Live Biotherapeutics for vaccines.\n<\/p>\n

\nFor more information, refer to https:\/\/www.4dpharmaplc.com<\/a><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210726005352\/en\/<\/a><\/span><\/p>\n

4D pharma
\n<\/strong>
Investor Relations: ir@4dpharmaplc.com<\/a><\/p>\n

N+1 Singer – Nominated Adviser and Joint Broker<\/strong> +44 (0)20 7496 3000
\n
Philip Davies \/ Iqra Amin \/ James Fischer (Corporate Finance)
\n
Tom Salvesen (Corporate Broking)\n<\/p>\n

Bryan Garnier & Co. Limited – Joint Broker<\/strong> +44 (0)20 7332 2500
\n
Dominic Wilson \/ Phil Walker\n<\/p>\n

Stern Investor Relations, Inc.<\/strong> +1-212-362-1200
\n
Julie Seidel Julie.seidel@sternir.com<\/a><\/p>\n

Image Box Communications<\/strong> +44 (0)20 8943 4685
\n
Neil Hunter \/ Michelle Boxall
\n
neil@ibcomms.agency<\/a> \/ michelle@ibcomms.agency<\/a><\/p>\n

KEYWORDS:<\/b> United Kingdom Europe<\/p>\n

INDUSTRY KEYWORDS:<\/b> Research FDA Clinical Trials Biotechnology General Health Pharmaceutical Health Science Oncology Other Science<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

4D pharma Announces Passing of Chief Financial Officer John Beck LEEDS, England–(BUSINESS WIRE)–4D pharma plc (AIM: DDDD, NASDAQ, LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, announces with great sadness that John Beck, Chief Financial Officer of 4D pharma, has passed away. \u201cWe are deeply saddened by John\u2019s passing. The entire 4D pharma community mourns this loss and, on behalf of our Board of Directors and employees, we extend our sincerest condolences to his family,\u201d said Duncan Peyton, Chief Executive Officer of 4D pharma. \u201cJohn\u2019s 30 years of experience in the financial and biopharmaceutical industries were invaluable to us in his role as Chief Financial Officer, and … <\/p>\n

Continue reading “4D pharma Announces Passing of Chief Financial Officer John Beck”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-517364","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\n4D pharma Announces Passing of Chief Financial Officer John Beck - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"4D pharma Announces Passing of Chief Financial Officer John Beck - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"4D pharma Announces Passing of Chief Financial Officer John Beck LEEDS, England–(BUSINESS WIRE)–4D pharma plc (AIM: DDDD, NASDAQ, LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, announces with great sadness that John Beck, Chief Financial Officer of 4D pharma, has passed away. \u201cWe are deeply saddened by John\u2019s passing. The entire 4D pharma community mourns this loss and, on behalf of our Board of Directors and employees, we extend our sincerest condolences to his family,\u201d said Duncan Peyton, Chief Executive Officer of 4D pharma. \u201cJohn\u2019s 30 years of experience in the financial and biopharmaceutical industries were invaluable to us in his role as Chief Financial Officer, and … Continue reading "4D pharma Announces Passing of Chief Financial Officer John Beck"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-26T12:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005352r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"4D pharma Announces Passing of Chief Financial Officer John Beck\",\"datePublished\":\"2021-07-26T12:03:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/\"},\"wordCount\":508,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210726005352r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/\",\"name\":\"4D pharma Announces Passing of Chief Financial Officer John Beck - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210726005352r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-07-26T12:03:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210726005352r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210726005352r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"4D pharma Announces Passing of Chief Financial Officer John Beck\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"4D pharma Announces Passing of Chief Financial Officer John Beck - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/","og_locale":"en_US","og_type":"article","og_title":"4D pharma Announces Passing of Chief Financial Officer John Beck - Market Newsdesk","og_description":"4D pharma Announces Passing of Chief Financial Officer John Beck LEEDS, England–(BUSINESS WIRE)–4D pharma plc (AIM: DDDD, NASDAQ, LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, announces with great sadness that John Beck, Chief Financial Officer of 4D pharma, has passed away. \u201cWe are deeply saddened by John\u2019s passing. The entire 4D pharma community mourns this loss and, on behalf of our Board of Directors and employees, we extend our sincerest condolences to his family,\u201d said Duncan Peyton, Chief Executive Officer of 4D pharma. \u201cJohn\u2019s 30 years of experience in the financial and biopharmaceutical industries were invaluable to us in his role as Chief Financial Officer, and … Continue reading \"4D pharma Announces Passing of Chief Financial Officer John Beck\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-26T12:03:33+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005352r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"4D pharma Announces Passing of Chief Financial Officer John Beck","datePublished":"2021-07-26T12:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/"},"wordCount":508,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005352r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/","name":"4D pharma Announces Passing of Chief Financial Officer John Beck - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005352r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-07-26T12:03:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005352r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005352r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-announces-passing-of-chief-financial-officer-john-beck\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"4D pharma Announces Passing of Chief Financial Officer John Beck"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=517364"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517364\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=517364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=517364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=517364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}